New Hire in Munich: M&A Expert Dr. Björn Biehl joins HEUKING as Partner
Dr. Björn Biehl (44) will start in mid-May as an Equity Partner in HEUKING's Munich office. He will strengthen the firm's M&A, Private Equity, and Restructuring practices.
Dr. Biehl was most recently a Partner in the Munich office of Greenberg Traurig LLP. Before that, he was a Partner at McDermott Will & Emery.
Dr. Björn Biehl advises clients on domestic and international M&A and private equity transactions, as well as corporate restructuring and insolvency matters. His practice focuses in particular on strategically complex carve-out and turnaround transactions at the intersection of M&A, restructuring, and insolvency law. He also has significant experience advising financial investors in the healthcare sector.
"Björn Biehl's arrival is an important step in expanding our Private Equity practice. We see considerable potential in the area of special situations in particular: these mandates require a seamless combination of transaction expertise and restructuring know-how. The resulting synergies allow us to advise investors in a more targeted and integrated manner across the entire lifecycle—from acquisition through complex restructurings to exit," said Boris Dürr, the firm's Managing Partner.
"With Björn Biehl joining us, we are strategically strengthening the intersection of M&A and restructuring. Especially in distressed situations and in transactions arising from insolvency proceedings—such as transfer restructurings and investor entry through restructuring plans—integrated solutions are critical. The close collaboration between our teams in both practice areas, reinforced by Björn Biehl as a highly distinguished expert, enables us to support our clients even more effectively in these particularly challenging transaction processes," said Prof. Dr. Georg Streit, Head of the Restructuring Practice."
Björn Biehl is an outstanding addition to our transactions team and our Healthcare and Life Sciences practice in Munich, which continues on its growth trajectory following the addition of the Life Sciences team from Taylor Wessing," said Dr. Oliver Treptow, Co-Head of the Healthcare & Life Sciences Practice Group in Munich.
